Being at Genetic Risk: Toward a Rhetoric of Care (RSA Series in Transdisciplinary Rhetoric Book 10)

★★★★★ 4.8 87 reviews

US$10.80
Price when purchased online
Free shipping Free 30-day returns

Sold and shipped by jannethtellez.com
We aim to show you accurate product information. Manufacturers, suppliers and others provide what you see here.
US$10.80
Price when purchased online
Free shipping Free 30-day returns

How do you want your item?
You get 30 days free! Choose a plan at checkout.
Shipping
Arrives Aug 17
Free
Pickup
Check nearby
Delivery
Not available

Sold and shipped by jannethtellez.com
Free 30-day returns Details

Product details

Management number 233631158 Release Date 2026/06/27 List Price US$10.80 Model Number 233631158
Category

Rhetorics of choice have dominated the biosocial discourses surrounding BRCA risk for decades, telling women at genetic risk for breast and ovarian cancers that they are free to choose how (and whether) to deal with their risk. Critics argue that women at genetic risk are, in fact, not free to choose but rather are forced to make particular choices. In Being at Genetic Risk, Kelly Pender argues for a change in the conversation around genetic risk that focuses less on choice and more on care.Being at Genetic Risk offers a new set of conceptual starting points for understanding what is at stake with a BRCA diagnosis and what the focus on choice obstructs from view. Through a praxiographic reading of the medical practices associated with BRCA risk, Pender’s analysis shows that genetic risk is not just something BRCA+ women know, but also something that they do. It is through this doing that genetic cancer risk becomes a reality in their lives, one that we can explain but not one that we can explain away.Well researched and thoughtfully argued, Being at Genetic Risk will be welcomed by scholars of rhetoric and communication, particularly those who work in the rhetoric of science, technology, and medicine, as well as scholars in allied fields who study the social, ethical, and political implications of genetic medicine. Pender’s insight will also be of interest to organizations that advocate for those at genetic risk of breast and ovarian cancers. Read more

ASIN B08L6TDXL3
XRay Not Enabled
ISBN13 978-0271083001
Edition 1st
Language English
File size 900 KB
Page Flip Enabled
Publisher Penn State University Press
Word Wise Enabled
Print length 256 pages
Accessibility Learn more
Screen Reader Supported
Publication date October 4, 2018
Enhanced typesetting Enabled

Correction of product information

If you notice any omissions or errors in the product information on this page, please use the correction request form below.

Correction Request Form

Customer ratings & reviews

4.8 out of 5
★★★★★
87 ratings | 36 reviews
How item rating is calculated
View all reviews
5 stars
87% (76)
4 stars
2% (2)
3 stars
1% (1)
2 stars
0% (0)
1 star
10% (9)
Sort by

There are currently no written reviews for this product.